Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPolar Capital Regulatory News (POLR)

Share Price Information for Polar Capital (POLR)

Share Price is delayed by 15 minutes
Get Live Data
844.00    -3.00 (-0.35%)
Bid:
844.00
Ask:
847.00
Spread: 3.00 (0.355%)
Market Cap: £796.00m
POLR Live PriceLast checked at - London Stock Exchange

Intraday Polar Capital Share Chart

AuM Update

13 Apr 2026 07:00

RNS Number : 0699A
Polar Capital Holdings PLC
13 April 2026
Β 

13 April 2026 Polar Capital Holdings plc

AuM Update

Β 

Β 

Polar Capital Holdings plc ("Polar Capital" or the "Group"), the specialist active asset management group, today provides its regular quarterly update of its unaudited statement of Assets under Management ("AuM") for the financial year to 31 March 2026.

Β 

Group AuMΒ (unaudited)

Β 

Polar Capital reports that as at 31 March 2026 its AuM was Β£30.6bn compared to Β£28.4bn at the end of December 2025, an increase of 8% over the quarter. In the quarter, AuM increased by net inflows of Β£1.4bn, fund performance and market movements of Β£0.8bn, offset by fund closures of Β£13m.

Β 

AuM movement in three months to 31 March 2026

Open ended

Funds

(Β£m)

Investment

Trusts

(Β£m)

Segregated mandates

(Β£m)

Total

(Β£m)

AuM at 1 January 2026

21,366

Β 

6,482

539

28,387

Net flows

Β 1,386

Β (5)

62

1,443

Fund closures1

(13)

-

-

(13)

Market movement

and performance

685

128

3

816

Total AuM at 31 March 2026

23,424

6,605

604

30,633

Β 

Β 

Β 

AuM movement in twelve months to 31 March 2026

Open ended

Funds

(Β£m)

Investment

Trusts

(Β£m)

Segregated mandates

(Β£m)

Total

(Β£m)

AuM at 1 April 2025

15,994

4,846

569

21,409

Net flows

Β 1,233

Β (237)

Β (94)

Β 902

Corporate actions2

-

Β (396)

-

(396)

Fund closures1

Β (75)

-

-

Β (75)

Market movement

and performance

Β 6,272

Β 2,392

Β 129

Β 8,793

Total AuM at 31 March 2026

23,424

6,605

604

30,633

1 Return of funds to investors upon the closure of the Polar Capital Emerging Market ex-China Stars Fund in February 2026, Polar Capital China Stars Fund in January 2026 and the Polar Capital Melchior European Opportunities Fund in November 2025.

2 Return of capital to investors in June 2025 as the Polar Capital Global Financials Trust underwent a 100% tender offer following which 44% of issued capital was tendered and in November 2025 when Polar Capital Global Healthcare Trust underwent a 100% tender offer following which 22% of issued capital was tendered.

Β 

Β 

Iain Evans, Chief Executive, commented:

"We have delivered a strong finish to the financial year, despite a backdrop of heightened geopolitical uncertainty and ongoing market volatility. Over the quarter, assets under management (AuM) increased by 8% to Β£30.6bn, up from Β£28.4bn at the end of December, supported by net inflows of Β£1.4bn.

Β 

"For the full financial year, AuM increased by 43% to Β£30.6bn, from Β£21.4bn at the end of March 2025, reflecting a combination of net inflows, fund performance and market movements. We delivered a second consecutive year of positive net inflows, totalling Β£902m (excluding corporate actions and fund closures), demonstrating the strength of our specialist investment capabilities.

Β 

"Flows during the quarter were broad-based, with several of our investment teams generating net inflows, led by Technology, Healthcare and Smart Energy. Net flows into our Global Technology (Β£722m) and Artificial Intelligence (Β£575m) funds remained particularly strong, driven by continued client interest in structural growth opportunities and supported by both increased allocations from existing clients and new client wins, notably across wealth and private bank channels in Europe and Asia.

Β 

"Our Healthcare strategies also contributed positively, including the launch of a new separately managed account in partnership with a Swiss wealth manager. In addition, Emerging Market Stars, Japan Value and Global Absolute Return funds each delivered net inflows, further highlighting the breadth of our platform.

Β 

"Net outflows were largely concentrated in North American (Β£97m), Global Insurance (Β£85m) and Asian Stars (Β£55m) funds, reflecting a small number of client-specific redemptions rather than any broader shift in demand or sentiment.

Β 

Outlook

"We have entered 2026 with positive net inflow momentum, although we remain mindful of the structural challenges facing the industry. Inflows were strongest in January and February, before moderating in March following the escalation of conflict in the Middle East. Encouragingly, positive momentum has continued into April to date.

"The geopolitical backdrop has become more uncertain, contributing to heightened market sensitivity, particularly in energy markets. Despite this, we remain confident in our positioning as a specialist boutique. As markets broaden and the pace of technological disruption, including AI, accelerates, the case for specialist active management is becoming increasingly compelling. Our focus on differentiated capabilities, deep expertise and disciplined execution positions us well to navigate the uncertainty and capture opportunities ahead for our clients and shareholders."

Β 

Polar Capital plans to announce its results for the financial year ended 31 March 2026 on 1 July 2026.

Β 

Β 

For further information please contact:

Β 

Polar Capital

Iain Evans (Chief Executive)

Samir Ayub (Chief Financial Officer)

Β 

+44 (0)20 7227 2700

Β 

Deutsche Numis - - Nomad and Joint Broker

Charles Farquhar

Duncan Monteith

Rajesh Iyer

Β 

+44 (0)20 7260 1000

Β 

Peel Hunt LLP - Joint Broker

Andrew Buchanan

Thomas Philpott

Β 

+44 (0)20 3597 8680

Β 

Β 

Camarco - PR

Ed Gascoigne-Pees

Jennifer Renwick

Phoebe Pugh

+44 (0)20 3757 4980

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
UPDEAKLEFDFKEFA
Date   Source Headline
12th Jul 201811:50 amRNSForm 8.3 - Consort Medical Plc
12th Jul 20187:00 amRNSAuM Update
11th Jul 201811:06 amRNSForm 8.3 - Consort Medical Plc
3rd Jul 20186:27 pmRNSHolding(s) in Company
3rd Jul 20186:20 pmRNSIssue of Equity
3rd Jul 201812:07 pmRNSForm 8.3 - Consort Medical Plc
2nd Jul 201810:23 amRNSTotal Voting Rights
29th Jun 20187:00 amRNSBlock Listing Application
28th Jun 20185:55 pmRNSAnnual Financial Report
25th Jun 20187:00 amRNSGroup Audited Results for year ended 31 March 2018
11th Jun 201811:27 amRNSNet Asset Value(s)
1st Jun 20187:41 amRNSTotal Voting Rights
24th May 201810:59 amRNSDirector/PDMR Shareholding
24th May 20189:35 amRNSIssue of Equity
23rd May 201811:00 amRNSNotice of Results
23rd May 20189:37 amRNSIssue of Equity
18th May 20181:02 pmRNSIssue of Equity
16th May 20185:49 pmRNSIssue of Equity
11th May 20187:00 amRNSIssue of Equity
10th May 20189:56 amRNSDirector/PDMR Shareholding
1st May 20183:52 pmRNSIssue of Equity
12th Apr 20187:00 amRNSAuM Update
5th Apr 20187:00 amRNSIssue of Equity
20th Mar 20182:19 pmRNSIssue of Equity
5th Feb 20183:15 pmRNSBlock listing Interim Review
18th Jan 20183:02 pmRNSHolding(s) in Company
18th Jan 20182:59 pmRNSHolding(s) in Company
18th Jan 20182:57 pmRNSDirector/PDMR Shareholding
17th Jan 20185:45 pmRNSIssue of Equity
11th Jan 20184:55 pmRNSIssue of Equity
11th Jan 20187:00 amRNSAUM Update
11th Dec 20177:00 amRNSUnaudited Interim Results
20th Nov 201710:43 amRNSNotice of Interim Results
15th Nov 201710:36 amRNSForm 8.3 - Gocompare.com Group Plc
8th Nov 201710:32 amRNSForm 8.3 - Aldermore Group Plc
7th Nov 201711:34 amRNSForm 8.3 - Aldermore Group Plc
1st Nov 20179:24 amRNSHolding(s) in Company
1st Nov 20177:00 amRNSTotal Voting Rights
31st Oct 201710:33 amRNSForm 8.3 - Aldermore Group Plc
30th Oct 201711:26 amRNSForm 8.3 - Aldermore Group Plc
27th Oct 201710:18 amRNSForm 8.3 - Aldermore Group Plc
26th Oct 201710:28 amRNSForm 8.3 - Aldermore Group Plc
25th Oct 201710:28 amRNSForm 8.3 - Aldermore Group Plc
24th Oct 20172:41 pmRNSTransaction in Own Shares
24th Oct 201712:30 pmRNSIssue of Equity
23rd Oct 20175:03 pmRNSHolding(s) in Company
23rd Oct 20172:19 pmRNSDirector/PDMR Shareholding
23rd Oct 20172:13 pmRNSIssue of Equity
18th Oct 201711:56 amRNSDirector/PDMR Shareholding
17th Oct 201712:53 pmRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.